RGEN
Repligen Corporation
Stock
$181.70+4.47 (+2.52%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $810M | $768M | $757M | $751M | $523M | $604M | $717M | $528M | $194M | $174M | $142M | $72M | $58M | $62M | $40M | $50M | $13M |
| Inventory | $187M | $170M | $143M | $202M | $238M | $184M | $95M | $55M | $42M | $39M | $25M | $18M | $12M | $12M | $11M | $2.0M | — |
| Current assets | $1.2B | $1.1B | $1.1B | $1.1B | $998M | $932M | $902M | $642M | $276M | $243M | $184M | $103M | $81M | $86M | $66M | $56M | — |
| Goodwill | $1.1B | $1.1B | $1.0B | $987M | $856M | $860M | $618M | $468M | $327M | $327M | $60M | $14M | $14M | $994K | $994K | $994K | — |
| Intangible assets | $358M | $386M | $398M | $407M | $361M | $337M | $287M | $213M | $135M | $145M | $30M | $13M | $15M | $6.2M | $7.2M | $1.2M | — |
| Total assets | $3.0B | $2.9B | $2.8B | $2.8B | $2.5B | $2.4B | $1.9B | $1.4B | $775M | $744M | $289M | $146M | $128M | $119M | $97M | $72M | — |
| Current liabilities | $133M | $136M | $127M | $165M | $404M | $375M | $319M | $48M | $130M | $25M | $21M | $19M | $11M | $11M | $11M | $4.6M | — |
| Long-term debt | $551M | $542M | $526M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total liabilities | $838M | $844M | $857M | $866M | $621M | $608M | $374M | $340M | $159M | $152M | $120M | $23M | $17M | $15M | $13M | $5.2M | — |
| Shareholders' equity | $2.1B | $2.1B | $2.0B | $2.0B | $1.9B | $1.8B | $1.5B | $1.1B | $616M | $592M | $169M | $123M | $112M | $104M | $84M | $67M | $66M |
| Shares outstanding | 56.4M | 56.3M | 56.1M | 55.8M | 55.6M | 55.3M | 54.8M | 52.1M | 43.9M | 43.6M | 33.8M | 33.0M | 32.8M | 31.9M | 31.2M | — | — |
| Current ratio | 9.05 | 8.37 | 8.41 | 6.74 | 2.47 | 2.48 | 2.83 | 13.28 | 2.12 | 9.63 | 8.74 | 5.50 | 7.58 | 7.64 | 6.16 | 12.08 | — |